Onconetix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ONCO research report →
About the company
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication.
- CEO
- David Allan White
- IPO
- 2022
- Employees
- 12
- HQ
- Cincinnati, OH, US
Price Chart
- Market Cap
- $319.17K
- P/E
- -0.11
- P/S
- 0.43
- P/B
- 0.05
- EV/EBITDA
- 0.34
- Div Yield
- 0.00%
- Gross Margin
- 79.63%
- Op Margin
- -922.72%
- Net Margin
- -1319.55%
- ROE
- -105.46%
- ROIC
- -56.35%
- Revenue
- $815.37K · -67.70%
- Net Income
- $-14,032,342 · 76.09%
- EPS
- $-4.73 · 99.09%
- Op Income
- $-6,344,856
- FCF YoY
- 8.04%
- 52W High
- $270.00
- 52W Low
- $0.88
- 50D MA
- $2.71
- 200D MA
- $69.98
- Beta
- 2.72
- Avg Volume
- 1.32M
Get TickerSpark's AI analysis on ONCO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 26 | HRT FINANCIAL LP | sell | 49,710 |
| Apr 17, 26 | HRT FINANCIAL LP | buy | 34,636 |
| Apr 16, 26 | HRT FINANCIAL LP | sell | 53,867 |
| Apr 20, 26 | HRT FINANCIAL LP | sell | 94,462 |
| Apr 15, 26 | HRT FINANCIAL LP | buy | 92,554 |
| Apr 14, 26 | HRT FINANCIAL LP | buy | 74,350 |
| Apr 14, 26 | HRT FINANCIAL LP | other | 0 |
| Mar 18, 26 | White David Allan | other | 0 |
| Mar 19, 26 | DORF SAMMY | other | 0 |
| Dec 5, 25 | Romano Sarah | other | 0 |
Our ONCO coverage
Recent articles, reports, and earnings notes.
No research on ONCO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ONCO report →Similar companies
Peers in the same neighborhood.